South Africa says J&J vaccine will be given to health workers in study

South Africa's health minister said on Wednesday that the country would vaccinate health workers with Johnson & Johnson's COVID-19 vaccine in the form of an "implementation study" in partnership with the Medical Research Council. The decision comes just days after the country put on hold the roll-out of the vaccine developed by AstraZeneca and Oxford University following data in a small clinical trial that showed it did not protect against mild to moderate illness from the fast-spreading 501Y.V2 variant of the virus.

Reuters | Cape Town | Updated: 10-02-2021 12:38 IST | Created: 10-02-2021 11:48 IST
South Africa says J&J vaccine will be given to health workers in study
Image Credit: Flickr

South Africa's health minister said on Wednesday that the country would vaccinate health workers with Johnson & Johnson's COVID-19 vaccine in the form of an "implementation study" in partnership with the Medical Research Council.

The decision comes just days after the country put on hold the roll-out of the vaccine developed by AstraZeneca and Oxford University following data in a small clinical trial that showed it did not protect against mild to moderate illness from the fast-spreading 501Y.V2 variant of the virus. "Given the outcome of the efficacy studies the department of health will continue with its planned phase one vaccination targeting the health workers and using the Johnson & Johnson vaccine instead of the AstraZeneca vaccine," Health Minister Zweli Mkhize said.

"The J&J vaccine has been proven to be effective ... The rollout of the vaccination will proceed in the form of an implementation study with a partnership between the Medical Research Council and the national department of health." Advisers would be able to give a considered view on how to deal with the AstraZeneca vaccines in the next week or so, he added.

Mkhize said the country has also secured COVID-19 vaccine doses from Pfizer Inc and that negotiations with Moderna were ongoing. The J&J vaccine was 89% effective at preventing severe disease and 57% against moderate-to-severe disease in the South African leg of the global trial. Ninety-five percent of infections observed in the local study were due to the 501Y.V2 variant first identified late last year.

The 501Y.V2 variant has alarmed health experts who have raised concerns about its ability to potentially evade the immune response generated by prior exposure to the coronavirus or vaccines.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

EasyJet sees Europe open for travel from late May

British airline easyJet said it expected to start to fly more from late May onwards and that by then most European countries should be open to British holidaymakers, painting an optimistic picture about the return of travel.In Britain, easy...

Trump-era spike in Israeli settlement growth has only begun

An aggressive Israeli settlement spree of over 9,000 homes during the Trump era pushed deeper into the occupied West Bank than ever before, according to an investigation.The trend puts the Biden administration in a tough bind if it follows ...

Latest OnePlus Nord N10 5G update brings March 2021 patch, fixes and improvements

OnePlus is rolling out a new software update to the Nord N10 5G. The latest over-the-air OTA update is arriving as OxygenOS 10.5.10 in the European units and OxygenOS 10.5.11 in the global units.The April update bumps up the OnePlusNord N10...

Kremlin tells U.S. it will act decisively if Washington imposes new sanctions - RIA

The Kremlin told Washington on Wednesday it would act decisively if the United States undertook any new unfriendly steps such as imposing sanctions, the RIA news agency reported, citing a foreign ministry source.It said the comments were ma...

Give Feedback